Used in pharmaceutical synthesis as a chiral intermediate for developing kinase inhibitors, particularly in oncology research. Its structure supports selective binding to target enzymes involved in cell signaling pathways, making it valuable in the design of active pharmaceutical ingredients for cancer treatment. The compound’s stereochemistry enhances biological activity and specificity, which is critical in optimizing drug efficacy and reducing off-target effects. It is also employed in structure-activity relationship (SAR) studies to improve metabolic stability and oral bioavailability in drug candidates.